← All companies

MIRM

Mirum Pharmaceuticals, Inc.

MIRM Nasdaq Pharmaceutical Preparations EDGAR ↗

$104.59

-8.00 -7.11%

Key statistics

from XBRL data in SEC filings

Market cap

$6.38B

Revenue (TTM)

$570M

Net income (TTM)

-$799M

EPS (TTM)

$-13.60

P/E ratio

—

Dividend yield

—

Free cash flow

$54.9M

Cash

$325M

Total assets

$891M

Gross margin

—

52-week range

$50.25 – $130.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 18, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events May 18, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Other events May 4, 2026 8-K Other events Apr 27, 2026 8-K/A Apr 8, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Results of operations (earnings release) Feb 25, 2026 8-K Completed an acquisition or disposition; Regulation FD disclosure; Other events Jan 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Other events Dec 19, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Dec 19, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Dec 8, 2025 8-K Other events Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Shareholder vote results May 30, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release) Feb 26, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Other events Jun 17, 2024 8-K Shareholder vote results Jun 6, 2024 8-K Other events May 31, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 10-K Fiscal year ended 2023-12-31 Mar 15, 2024 8-K Results of operations (earnings release) Feb 28, 2024 8-K Director or officer change Jan 16, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 8, 2024 8-K Other events Dec 18, 2023 10-Q Quarter ended 2023-09-30 Nov 2, 2023